ADDRESSING THE TECHNICAL AND CLINICAL CHALLENGES OF NEXT-GENERATION CELL THERAPIES AND REGENERATIVE MEDICINE
ABOUT US
As bench scientists working with stem cells since 2000, we recognized the need for optimized tools and methods to advance our in-house projects. We are first-principles problem solvers, striving to continuously optimize workflows, improve safety profiles, and ultimately lower the cost of developing next-generation cell therapies.
Company History
Cellular Engineering Technologies, Inc. (CET) was founded in Coralville, IA, by Dr. Alan Moy and Anant Kamath to develop research tools for stem cell applications.
2000
CET launches first characterized human somatic stem cell line products for research applications.
2005
CET launches a portfolio of cell-specific media formulations to promote efficient stem cell expansion and differentiation. Our cell culture media are optimized for robust expansion and efficient differentiation with our proprietary cell lines.
2006
CET launches first induced pluripotent stem cell (iPSC) line for research applications, programmed using CET's proprietary method that is virus and oncogene-free and suitable for adherent and suspension-based cell lines.
Our non-viral methods result in efficient programming, minimal passaging, and the safest clinical risk profile for therapeutic development.
2020
CET is awarded an NIH Phase II SBIR grant for "Improving the Reproducibility and Genetic Stability of IPSC and Differentiated Cells Through Oncogene-Free Reprogramming and Fully Human Growth Factors".
2022
CET manufactures first batch of human growth factor proteins from immortalized somatic stem cells.
CET's core method patent for programming iPSCs was published on March 8th.
2023
CET manufactures first batch of human growth factors from proprietary yeast lines.
CET has entered into a manufacturing partnership with the University of Iowa’s Center for Biocatalysis and Bioprocessing to manufacture cGMP-grade human growth factors.
OPTIMIZE YOUR CELL-BASED WORKFLOWS
When faced with in-house technical challenges and budget constraints, we returned to first principles to design optimized technologies that are scalable, efficient, and cost-effective. Need a custom solution for a challenging cell manufacturing application?
Contact us today to learn how our innovative products can address your technical pain points.